1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd
- MORE
The growing instances of drug abuse are compelling various governments agencies such as the US FDA, the CDC, and the Drug Enforcement Agency (DEA) impose stringent regulations pertaining to the use of drugs. Implementation of these regulations is driving the growth of the global drugs of abuse testing market. For instance, the researchers in the US are required to get approval from several organizations such as the National Institute on Drug Abuse (NIDA), the US FDA, and the DEA to procure cannabis for their research purposes. Additionally, researchers must secure additional approvals from various state government departments where the research is being conducted. These factors are expected to drive the growth of the market at a CAGR of nearly 6% during 2019-2023.
Market Overview
Increased strategic developments
Vendors in the market are focusing on improving their product offerings and innovations to expand their product portfolios and ensure the availability of drugs of abuse testing to end-users such as research laboratories and academic institutions. Other strategic developments such as new product launches, joint ventures, collaborations, investments, and partnerships, and acquisitions adopted by the vendors are expected to fuel the growth of the global drugs of abuse testing market size during the forecast period.
Manipulation of drug screening tests
There are instances of people evading tests for illicit drugs by manipulating the specimen that was supposed to be subjected to the tests. For example, the easy availability of chemicals such as laundry detergent, table salt, and toilet bowl cleaners give people the liberty to adulterate the specimens to manipulate drug screening tests. This is expected to hinder the growth of the global drugs of abuse testing market size.
Competitive Landscape
The market appears to be fairly concentrated with few players occupying the market share. Companies such as Abbott and Bio-Rad Laboratories Inc. have intensified competition. Factors such as stringent regulatory control on the procurement of cannabis and increased strategic developments will provide significant growth opportunities for drugs of abuse testing companies. Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.
Market Overview
Increased strategic developments
Vendors in the market are focusing on improving their product offerings and innovations to expand their product portfolios and ensure the availability of drugs of abuse testing to end-users such as research laboratories and academic institutions. Other strategic developments such as new product launches, joint ventures, collaborations, investments, and partnerships, and acquisitions adopted by the vendors are expected to fuel the growth of the global drugs of abuse testing market size during the forecast period.
Manipulation of drug screening tests
There are instances of people evading tests for illicit drugs by manipulating the specimen that was supposed to be subjected to the tests. For example, the easy availability of chemicals such as laundry detergent, table salt, and toilet bowl cleaners give people the liberty to adulterate the specimens to manipulate drug screening tests. This is expected to hinder the growth of the global drugs of abuse testing market size.
Competitive Landscape
The market appears to be fairly concentrated with few players occupying the market share. Companies such as Abbott and Bio-Rad Laboratories Inc. have intensified competition. Factors such as stringent regulatory control on the procurement of cannabis and increased strategic developments will provide significant growth opportunities for drugs of abuse testing companies. Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 12: VENDOR LANDSCAPE
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Instruments - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Instruments - Year-over-year growth 2019-2023 (%)
Exhibit 21: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Abbott - Vendor overview
Exhibit 44: Abbott - Business segments
Exhibit 45: Abbott - Organizational developments
Exhibit 46: Abbott - Geographic focus
Exhibit 47: Abbott - Segment focus
Exhibit 48: Abbott - Key offerings
Exhibit 49: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 50: Bio-Rad Laboratories Inc. - Product segments
Exhibit 51: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 52: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 53: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 54: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 55: Danaher Corp. - Vendor overview
Exhibit 56: Danaher Corp. - Business segments
Exhibit 57: Danaher Corp. - Organizational developments
Exhibit 58: Danaher Corp. - Geographic focus
Exhibit 59: Danaher Corp. - Segment focus
Exhibit 60: Danaher Corp. - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd - Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd - Product segments
Exhibit 63: F. Hoffmann-La Roche Ltd - Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd - Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd - Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd - Key offerings
Exhibit 67: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 68: Thermo Fisher Scientific Inc. - Business segments
Exhibit 69: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 70: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 71: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 72: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Instruments - Market size and forecast 2018-2023
- Consumables - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Instruments - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Instruments - Year-over-year growth 2019-2023 (%)
Exhibit 21: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Abbott - Vendor overview
Exhibit 44: Abbott - Business segments
Exhibit 45: Abbott - Organizational developments
Exhibit 46: Abbott - Geographic focus
Exhibit 47: Abbott - Segment focus
Exhibit 48: Abbott - Key offerings
Exhibit 49: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 50: Bio-Rad Laboratories Inc. - Product segments
Exhibit 51: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 52: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 53: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 54: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 55: Danaher Corp. - Vendor overview
Exhibit 56: Danaher Corp. - Business segments
Exhibit 57: Danaher Corp. - Organizational developments
Exhibit 58: Danaher Corp. - Geographic focus
Exhibit 59: Danaher Corp. - Segment focus
Exhibit 60: Danaher Corp. - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd - Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd - Product segments
Exhibit 63: F. Hoffmann-La Roche Ltd - Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd - Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd - Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd - Key offerings
Exhibit 67: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 68: Thermo Fisher Scientific Inc. - Business segments
Exhibit 69: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 70: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 71: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 72: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd
- MORE
The following companies are recognised as the key players in the global drugs of abuse testing market: Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growth of luxury cannabis products.”
According to the report, one of the major drivers for this market is the stringent regulatory control on the procurement of cannabis.
Further, the report states that one of the major factors hindering the growth of this market is the manipulation of drug screening tests.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growth of luxury cannabis products.”
According to the report, one of the major drivers for this market is the stringent regulatory control on the procurement of cannabis.
Further, the report states that one of the major factors hindering the growth of this market is the manipulation of drug screening tests.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Abbott
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
